nSAGE


nSAGE is a bio-venture that focuses on gene editing and stem cell engineering technologies. The company is pursuing global industrialization of gene-engineered stem cells and their related products using CRISPR/Cas9 technology in Korea. nSAGE's core technologies are generation of primed stem cells and their exosomes through single cell level analysis. The major therapeutic target of nSAGE is macrophage and inflammation-mediated intractable diseases.

nSAGE is a bio-venture that focuses on gene editing and stem cell engineering technologies. The company is pursuing global industrialization of gene-engineered stem cells and their related products using CRISPR/Cas9 technology in Korea. nSAGE's core ...Show all

Company (Alive / Active)

Phone:

Fax:




South Korea

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
nSAGE $2.5M Jun 28, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related nSAGE Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)